Phase ? Study to Evaluate the Efficacy and Safety of Regdanvimab for Patients with Mild to Moderate Symptoms of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
100 Clinical Results associated with Incheon Medical Center
0 Patents (Medical) associated with Incheon Medical Center
100 Deals associated with Incheon Medical Center
100 Translational Medicine associated with Incheon Medical Center